DMD and Duchenne muscular dystrophy: For example, eteplirsen is an FDA-approved translation-blocking morpholino ASO used in Duchenne muscular dystrophy (DMD) to induce skipping of the mutated exon in dystrophin, which allows the translation of an almost full-length functional form of the protein encoded by the DMD gene.